RNF5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.059000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.478600E-01
Normal-vs-Stage2
7.236400E-01
Normal-vs-Stage3
4.167400E-01
Normal-vs-Stage4
6.777600E-01
Stage1-vs-Stage2
5.137000E-01
Stage1-vs-Stage3
6.786000E-01
Stage1-vs-Stage4
8.274800E-01
Stage2-vs-Stage3
1.683230E-01
Stage2-vs-Stage4
8.629000E-01
Stage3-vs-Stage4
4.901800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.497600E-01
Normal-vs-AfricanAmerican
7.284800E-01
Normal-vs-Asian
5.600000E-01
Caucasian-vs-AfricanAmerican
2.803600E-01
Caucasian-vs-Asian
7.943900E-02
AfricanAmerican-vs-Asian
7.747200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.907800E-01
Normal-vs-Female
6.046000E-01
Male-vs-Female
4.098600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.723800E-01
Normal-vs-Age(41-60Yrs)
7.297600E-01
Normal-vs-Age(61-80Yrs)
6.714600E-01
Normal-vs-Age(81-100Yrs)
9.315600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.514200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.019200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.153200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.128600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.047000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.283800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.210200E-01
Normal-vs-Daily Drinker
3.347000E-01
Normal-vs-Weekly Drinker
6.224800E-01
Normal-vs-Occasional Drinker
7.940600E-01
Normal-vs-Social Drinker
3.297800E-01
Non Drinker-vs-Daily Drinker
1.794750E-01
Non Drinker-vs-Weekly Drinker
7.826600E-01
Non Drinker-vs-Occasional Drinker
9.689800E-01
Non Drinker-vs-Social Drinker
3.347600E-01
Daily Drinker-vs-Weekly Drinker
2.997200E-01
Daily Drinker-vs-Occasional Drinker
1.524230E-01
Daily Drinker-vs-Social Drinker
7.540200E-01
Weekly Drinker-vs-Occasional Drinker
7.204800E-01
Weekly Drinker-vs-Social Drinker
4.240600E-01
Occasional Drinker-vs-Social Drinker
2.505800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.752200E-01
Normal-vs-Grade 2
3.155600E-02
Normal-vs-Grade 3
5.965800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.655900E-03
Grade 1-vs-Grade 3
2.274000E-01
Grade 1-vs-Grade 4
2.752200E-01
Grade 2-vs-Grade 3
5.626200E-02
Grade 2-vs-Grade 4
3.155600E-02
Grade 3-vs-Grade 4
5.965800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.326800E-01
Normal-vs-NonDiabetic
7.993400E-01
Diabetic-vs-NonDiabetic
1.298200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.228000E-01
Normal-vs-NoPancreatitis
6.829800E-01
Pancreatitis-vs-NoPancreatitis
5.198400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.768400E-01
Normal-vs-N1
6.625000E-01
N0-vs-N1
4.957400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.762400E-01
Normal-vs-TP53-NonMutant
6.462800E-01
TP53-Mutant-vs-TP53-NonMutant
1.212470E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
